PMC:7361216 / 2277-2716
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T25 | 108-111 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T26 | 136-142 | Body_part | denotes | myelin | http://purl.org/sig/ont/fma/fma62977 |
| T27 | 371-383 | Body_part | denotes | carbohydrate | http://purl.org/sig/ont/fma/fma82737 |
| T28 | 401-414 | Body_part | denotes | myelin sheath | http://purl.org/sig/ont/fma/fma62983 |
| T29 | 430-438 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T10 | 136-142 | Body_part | denotes | myelin | http://purl.obolibrary.org/obo/UBERON_0000345 |
| T11 | 401-414 | Body_part | denotes | myelin sheath | http://purl.obolibrary.org/obo/UBERON_0000347 |
| T12 | 401-407 | Body_part | denotes | myelin | http://purl.obolibrary.org/obo/UBERON_0000345 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T8 | 344-362 | Disease | denotes | neurologic disease | http://purl.obolibrary.org/obo/MONDO_0005071 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31 | 33-34 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T32 | 281-282 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T33 | 303-304 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T34 | 337-338 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T35 | 369-370 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T22 | 149-156 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T23 | 166-178 | Chemical | denotes | glycopolymer | http://purl.obolibrary.org/obo/CHEBI_53590|http://purl.obolibrary.org/obo/CHEBI_61420 |
| T25 | 371-383 | Chemical | denotes | carbohydrate | http://purl.obolibrary.org/obo/CHEBI_16646 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 355-362 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T20 | 166-178 | Chemical | denotes | glycopolymer | http://purl.obolibrary.org/obo/CHEBI_53590|http://purl.obolibrary.org/obo/CHEBI_61420 |
| T22 | 371-383 | Chemical | denotes | carbohydrate | http://purl.obolibrary.org/obo/CHEBI_16646 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 0-439 | Sentence | denotes | The present Editorial highlights a study by Aliu and colleagues, entitled “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer” published in the current issue of the Journal of Neurochemistry, in which the authors have developed a therapy directed to a highly specific target to treat a rare neurologic disease where a carbohydrate component of the myelin sheath is attacked by antibody. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T8 | 136-142 | Body_part | denotes | myelin | http://purl.obolibrary.org/obo/UBERON_0000345 |
| T9 | 401-414 | Body_part | denotes | myelin sheath | http://purl.obolibrary.org/obo/UBERON_0000347 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 66 | 104-107 | Gene | denotes | MAG | Gene:4099 |
| 70 | 344-362 | Disease | denotes | neurologic disease | MESH:D020271 |
| 67 | 371-383 | Chemical | denotes | carbohydrate | MESH:D002241 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T33 | 104-107 | Protein | denotes | MAG | https://www.uniprot.org/uniprot/Q567S4 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T25 | 108-111 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T26 | 136-142 | Body_part | denotes | myelin | http://purl.org/sig/ont/fma/fma62977 |
| T27 | 371-383 | Body_part | denotes | carbohydrate | http://purl.org/sig/ont/fma/fma82737 |
| T28 | 401-414 | Body_part | denotes | myelin sheath | http://purl.org/sig/ont/fma/fma62983 |
| T29 | 430-438 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T10 | 344-362 | Disease | denotes | neurologic disease | http://purl.obolibrary.org/obo/MONDO_0005071 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 0-439 | Sentence | denotes | The present Editorial highlights a study by Aliu and colleagues, entitled “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer” published in the current issue of the Journal of Neurochemistry, in which the authors have developed a therapy directed to a highly specific target to treat a rare neurologic disease where a carbohydrate component of the myelin sheath is attacked by antibody. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 66 | 104-107 | Gene | denotes | MAG | Gene:4099 |
| 67 | 371-383 | Chemical | denotes | carbohydrate | MESH:D002241 |
| 70 | 344-362 | Disease | denotes | neurologic disease | MESH:D020271 |